Michael E. McFadden
CIK 1748333 · Chief Executive Officer · last filed 2026-01-13
Michael E. McFadden is a Chief Executive Officer who has filed 5 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for ACOG, was dated Jan 13, 2026. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.23M
2
5
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACOG | Chief Executive Officer | 204,691 | $5.99 | $1.23M | $0 | 2 | 2026-01-13 |
| Urovant Sciences Ltd. (UROV) Delisted | CCO/Urovant Sciences, Inc. | — | $16.24 | — | $0 | 2 | 2019-01-08 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-13 | ACOG | Grant (A) | +190,549 | $0 | EDGAR |
| 2025-02-27 | ACOG | Grant (A) | — | $0 | EDGAR |
| 2024-11-15 | — | Buy (P) | +2,608 | $15.0K | |
| 2019-01-08 | Urovant Sciences Ltd. (UROV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-10-17 | Urovant Sciences Ltd. (UROV) Delisted | Grant (A) | — | $0 | EDGAR |